1. Home
  2. PFE
  3. PFE News

Latest Pfizer Inc. (PFE) News on November 26, 2025

J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?
PFE

Zacks

19 hours ago

J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?

Is This the Best Value Stock to Buy While Markets Are Volatile?
PFE

Motley Fool

20 hours ago

Is This the Best Value Stock to Buy While Markets Are Volatile?

Should FDA Approval of PADCEV-Keytruda Combo Shape the Outlook for Pfizer (PFE) Investors?
PFE

Simply Wall St.

a day ago

Should FDA Approval of PADCEV-Keytruda Combo Shape the Outlook for Pfizer (PFE) Investors?

Bristol Myers Pops On A 'Surprisingly Positive' Update From Key Rival Bayer
PFE

Investor's Business Daily

a day ago

Bristol Myers Pops On A 'Surprisingly Positive' Update From Key Rival Bayer

Mamdani Taps Ex-Goldman Partner, Developer for Transition Team
PFE

Bloomberg

a day ago

Mamdani Taps Ex-Goldman Partner, Developer for Transition Team

Moderna is the S&P 500's most shorted stock: Here's why
PFE

Yahoo Finance Video

2 days ago

Moderna is the S&P 500's most shorted stock: Here's why

Novo's $5 Billion Alzheimer's Dream Just Died--And Investors Are Cratering the Stock
PFE

GuruFocus.com

2 days ago

Novo's $5 Billion Alzheimer's Dream Just Died--And Investors Are Cratering the Stock

FDA Approves MRK's Keytruda & Keytruda SC Combo in Bladder Cancer
PFE

Zacks

2 days ago

FDA Approves MRK's Keytruda & Keytruda SC Combo in Bladder Cancer

Lilly Crosses $1 Trillion Market Cap: Here's What Is Driving the Rally
PFE

Zacks

2 days ago

Lilly Crosses $1 Trillion Market Cap: Here's What Is Driving the Rally

RVL Pharmaceuticals Announces Leadership Appointments to Accelerate Next Phase of Growth and Commercial Momentum
PFE

PR Newswire

2 days ago

RVL Pharmaceuticals Announces Leadership Appointments to Accelerate Next Phase of Growth and Commercial Momentum

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)
PFE

GlobeNewswire

2 days ago

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)

PFE

MT Newswires

2 days ago

Guggenheim Adjusts Price Target on Pfizer to $35 From $33, Maintains Buy Rating

UnitedHealth Group Incorporated (UNH) Outlook Strong, Analysts Watch Closely
PFE

Insider Monkey

3 days ago

UnitedHealth Group Incorporated (UNH) Outlook Strong, Analysts Watch Closely

2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon
PFE

Motley Fool

4 days ago

2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon

Does Pfizer’s AI-Powered R&D Signal a New Opportunity for 2025?
PFE

Simply Wall St.

4 days ago

Does Pfizer’s AI-Powered R&D Signal a New Opportunity for 2025?

Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know
PFE

StockStory

4 days ago

Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), as Perioperative Treatment for Adults with Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
PFE

Business Wire

4 days ago

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), as Perioperative Treatment for Adults with Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

PFE

MT Newswires

4 days ago

Sector Update: Health Care Stocks Higher Late Afternoon

PFE

MT Newswires

5 days ago

Pfizer, Astellas Say FDA Approves Padcev-Keytruda Combo in Bladder Cancer

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
PFE

Business Wire

5 days ago

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

Is Pfizer's 6.9%-Yielding Dividend Still Safe?
PFE

Motley Fool

6 days ago

Is Pfizer's 6.9%-Yielding Dividend Still Safe?

Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street.
PFE

Investor's Business Daily

6 days ago

Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street.

This Drugmaker Is Too Cheap to Ignore. Why Bristol Is a Buy.
PFE

Barrons.com

6 days ago

This Drugmaker Is Too Cheap to Ignore. Why Bristol Is a Buy.

BMO Launches New CDRs With Exposure to U.S. Stocks Including Apple, Intel, Mastercard, Pfizer and Visa
PFE

CNW Group

6 days ago

BMO Launches New CDRs With Exposure to U.S. Stocks Including Apple, Intel, Mastercard, Pfizer and Visa

Zoetis (ZTS): Buy, Sell, or Hold Post Q3 Earnings?
PFE

StockStory

6 days ago

Zoetis (ZTS): Buy, Sell, or Hold Post Q3 Earnings?

Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too?
PFE

Barchart

6 days ago

Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too?

PFE

MT Newswires

6 days ago

Sector Update: Health Care Stocks Softer Late Afternoon

PFE

MT Newswires

6 days ago

Update: Pfizer, Tris Pharma Settle Texas ADHD Drug Case for $41.5 Million

Ewing Sarcoma Market Research Report 2025-2035: Salarius, Eli Lilly, Pfizer, and BioAtla Lead by Driving Innovations in the Development of Novel Targeted Therapies
PFE

GlobeNewswire

7 days ago

Ewing Sarcoma Market Research Report 2025-2035: Salarius, Eli Lilly, Pfizer, and BioAtla Lead by Driving Innovations in the Development of Novel Targeted Therapies

Bacterial Vaginosis Market Research Report 2025-2035, Competitive Analysis of Pfizer, Bayer, Exeltis USA, Lupin, Osel
PFE

GlobeNewswire

7 days ago

Bacterial Vaginosis Market Research Report 2025-2035, Competitive Analysis of Pfizer, Bayer, Exeltis USA, Lupin, Osel

Metrorrhagia Market Analysis Report 2025-2035, Profiles of Pfizer, Sandoz, Bayer, Actavis Pharma, Noven Pharmaceuticals, Theramex, Pantarhei Bioscience, AbbVie, Neurocrine Biosciences, Merck
PFE

GlobeNewswire

7 days ago

Metrorrhagia Market Analysis Report 2025-2035, Profiles of Pfizer, Sandoz, Bayer, Actavis Pharma, Noven Pharmaceuticals, Theramex, Pantarhei Bioscience, AbbVie, Neurocrine Biosciences, Merck

Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery
PFE

PR Newswire

7 days ago

Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery

Business Leaders Set to Welcome Saudi Investments after a Combative White House Meeting
PFE

Barrons.com

7 days ago

Business Leaders Set to Welcome Saudi Investments after a Combative White House Meeting

PFE

MT Newswires

7 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

Novo Nordisk, Eli Lilly Weight Loss Price War Heats Up. Why It’s a Worry for the Stocks.
PFE

Barrons.com

7 days ago

Novo Nordisk, Eli Lilly Weight Loss Price War Heats Up. Why It’s a Worry for the Stocks.

Can AI Drive Peloton's Comeback?
PFE

Motley Fool

8 days ago

Can AI Drive Peloton's Comeback?

Nuvalent aiming for approval on pivotal trial data for NSCLC candidate
PFE

Clinical Trials Arena

8 days ago

Nuvalent aiming for approval on pivotal trial data for NSCLC candidate

The Weight-Loss Craze Is About to Mint a Trillion-Dollar Company
PFE

The Wall Street Journal

8 days ago

The Weight-Loss Craze Is About to Mint a Trillion-Dollar Company

[Latest] Global NUT Midline Carcinoma Treatment Market Size/Share Worth USD 93.34 Billion by 2034 at a 15.26% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
PFE

GlobeNewswire

8 days ago

[Latest] Global NUT Midline Carcinoma Treatment Market Size/Share Worth USD 93.34 Billion by 2034 at a 15.26% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)

Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Pfizer (NYSE:PFE)
PFE

StockStory

8 days ago

Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Pfizer (NYSE:PFE)

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion
PFE

Barrons.com

9 days ago

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion

2 Giant Healthcare Stocks to Buy Hand Over Fist in November
PFE

Motley Fool

9 days ago

2 Giant Healthcare Stocks to Buy Hand Over Fist in November

Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment
PFE

Investor's Business Daily

9 days ago

Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment

MRK to Buy Cidara for $9.2B: Focus on Buyout Spree Heading Into 2026
PFE

Zacks

9 days ago

MRK to Buy Cidara for $9.2B: Focus on Buyout Spree Heading Into 2026

PFE

MT Newswires

9 days ago

Daiwa Securities Adjusts Price Target on Pfizer to $27 From $29, Maintains Outperform Rating

Down 55%, Should You Buy the Dip on Pfizer?
PFE

Motley Fool

9 days ago

Down 55%, Should You Buy the Dip on Pfizer?

Values that Pfizer and Delta CEOs draw on for great leadership
PFE

Yahoo Finance

11 days ago

Values that Pfizer and Delta CEOs draw on for great leadership

Is Pfizer Stock a Buy After This $10 Billion Acquisition?
PFE

Motley Fool

11 days ago

Is Pfizer Stock a Buy After This $10 Billion Acquisition?

A Look at BioNTech (NasdaqGS:BNTX) Valuation Following Pfizer’s Share Sale Announcement
PFE

Simply Wall St.

11 days ago

A Look at BioNTech (NasdaqGS:BNTX) Valuation Following Pfizer’s Share Sale Announcement

How Recent Moves Are Rewriting the Story for Pfizer
PFE

Simply Wall St.

12 days ago

How Recent Moves Are Rewriting the Story for Pfizer

Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since
PFE

MarketBeat

12 days ago

Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since

Health Care Roundup: Market Talk
PFE

The Wall Street Journal

12 days ago

Health Care Roundup: Market Talk

To Wall Street, a new bidding war puts Alkermes in a tough spot
PFE

BioPharma Dive

12 days ago

To Wall Street, a new bidding war puts Alkermes in a tough spot

Why Pfizer (PFE) Shares Are Sliding Today
PFE

StockStory

12 days ago

Why Pfizer (PFE) Shares Are Sliding Today

PFE

Financial Times

12 days ago

Merck agrees $9.2bn deal for flu-prevention biotech Cidara

Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
PFE

Zacks

12 days ago

Pharma ETFs in Spotlight Following Robust Q3 Earnings Results

Pfizer Cuts BioNTech Stake by More Than Half
PFE

GuruFocus.com

12 days ago

Pfizer Cuts BioNTech Stake by More Than Half

PFE

MT Newswires

12 days ago

Rothschild & Co Redburn Adjusts Price Target on Pfizer to $24 From $25, Maintains Neutral Rating

Is that pharma influencer human or AI?
PFE

Pharma Voice

12 days ago

Is that pharma influencer human or AI?

Novo’s New Chairman Urged to Curb Risk After Metsera Drama
PFE

Bloomberg

12 days ago

Novo’s New Chairman Urged to Curb Risk After Metsera Drama

Novo Nordisk A/S: Candidate for the Board of Directors will not seek election
PFE

GlobeNewswire

12 days ago

Novo Nordisk A/S: Candidate for the Board of Directors will not seek election

PFE

MT Newswires

12 days ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls
PFE

The Fly

13 days ago

Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls

Inside Yahoo Finance Invest 2025: Elon Musk's $1 trillion pay package, crypto cracks, and AI bubbles
PFE

Yahoo Finance

13 days ago

Inside Yahoo Finance Invest 2025: Elon Musk's $1 trillion pay package, crypto cracks, and AI bubbles

Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results
PFE

PR Newswire

13 days ago

Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results

CPHI 2025: ‘handprint’ metric bridges pharma sustainability and economic value
PFE

Pharmaceutical Technology

13 days ago

CPHI 2025: ‘handprint’ metric bridges pharma sustainability and economic value

PFE

MT Newswires

13 days ago

Scotiabank Initiates Pfizer at Sector Outperform With $30 Price Target

Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?
PFE

Motley Fool

13 days ago

Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?

3 Healthcare Stocks Topping a 2025 List of Dividend Yields
PFE

Motley Fool

13 days ago

3 Healthcare Stocks Topping a 2025 List of Dividend Yields

The FDA Has a New Drug Chief. What it Means for Biotech Stocks.
PFE

Barrons.com

14 days ago

The FDA Has a New Drug Chief. What it Means for Biotech Stocks.

Why Metsera's Share Price Is Plummeting This Week
PFE

Motley Fool

14 days ago

Why Metsera's Share Price Is Plummeting This Week

1 Large-Cap Stock for Long-Term Investors and 2 We Turn Down
PFE

StockStory

14 days ago

1 Large-Cap Stock for Long-Term Investors and 2 We Turn Down

TD Cowen Maintains a Hold on Pfizer Inc. (PFE) With a $30 PT
PFE

Insider Monkey

14 days ago

TD Cowen Maintains a Hold on Pfizer Inc. (PFE) With a $30 PT

PFE

Morningstar Research

14 days ago

Analyst Report: Viatris Inc.

Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know
PFE

StockStory

14 days ago

Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know

Jim Cramer Says “I Think Pfizer’s Very Smart to Buy Metsera”
PFE

Insider Monkey

14 days ago

Jim Cramer Says “I Think Pfizer’s Very Smart to Buy Metsera”

Why Metsera is 'in better hands' with Pfizer than Novo Nordisk
PFE

Yahoo Finance Video

15 days ago

Why Metsera is 'in better hands' with Pfizer than Novo Nordisk

Markets exhale as Novo Nordisk withdraws from Metsera bidding war
PFE

Euronews

15 days ago

Markets exhale as Novo Nordisk withdraws from Metsera bidding war

Alpha-1 Antitrypsin Deficiency Disease Market Research Report 2025, Competitive Analysis of Shire, GSK, CSL Behring, AstraZeneca, Grifols, Teva Pharma, Boehringer Ingelheim, Kamada, Pfizer, Baxter
PFE

GlobeNewswire

15 days ago

Alpha-1 Antitrypsin Deficiency Disease Market Research Report 2025, Competitive Analysis of Shire, GSK, CSL Behring, AstraZeneca, Grifols, Teva Pharma, Boehringer Ingelheim, Kamada, Pfizer, Baxter

Sickle Cell Disease Treatment Market Research Report 2025 Featuring Novartis, Pfizer, Bluebird Bio, GlycoMimetics, Emmaus Medical, BMS, CRISPR Therapeutics, Graphite Bio
PFE

GlobeNewswire

15 days ago

Sickle Cell Disease Treatment Market Research Report 2025 Featuring Novartis, Pfizer, Bluebird Bio, GlycoMimetics, Emmaus Medical, BMS, CRISPR Therapeutics, Graphite Bio

Pfizer's (NYSE:PFE) Solid Earnings Are Supported By Other Strong Factors
PFE

Simply Wall St.

15 days ago

Pfizer's (NYSE:PFE) Solid Earnings Are Supported By Other Strong Factors

Obesity Drugs Are About to Go Mass-Market
PFE

The Wall Street Journal

15 days ago

Obesity Drugs Are About to Go Mass-Market

Vaccines Market Research and Forecast Report 2025-2030: Growing Focus on Vaccine Development, New Product Launches, and Large-scale Immunization Programs Continues to Accelerate Growth
PFE

GlobeNewswire

15 days ago

Vaccines Market Research and Forecast Report 2025-2030: Growing Focus on Vaccine Development, New Product Launches, and Large-scale Immunization Programs Continues to Accelerate Growth

Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
PFE

Motley Fool

15 days ago

Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?

Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring
PFE

Motley Fool

15 days ago

Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring

Novo Nordisk Shares Pop After Stepping Back From Metsera Chase
PFE

GuruFocus.com

15 days ago

Novo Nordisk Shares Pop After Stepping Back From Metsera Chase

Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion
PFE

Investor's Business Daily

16 days ago

Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion

Pfizer & Metsera, Monday.com, Instacart: Trending Tickers
PFE

Yahoo Finance Video

16 days ago

Pfizer & Metsera, Monday.com, Instacart: Trending Tickers

PFE

MT Newswires

16 days ago

Sector Update: Health Care Stocks Mixed Premarket Monday

PFE

MT Newswires

16 days ago

Investors Monitor Potential Breakthrough to End Government Shutdown, Driving Premarket Gains for US Equity Futures

Here Are Monday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Alphabet, Apple, Eli Lilly, CarMax, HubSpot, and More
PFE

24/7 Wall St.

16 days ago

Here Are Monday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Alphabet, Apple, Eli Lilly, CarMax, HubSpot, and More

PFE

MT Newswires

16 days ago

Sector Update: Health Care

PFE

MT Newswires

16 days ago

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Amid Hopes of Government Reopening

5 Things to Know Before the Stock Market Opens
PFE

Investopedia

16 days ago

5 Things to Know Before the Stock Market Opens

Inside Yahoo Finance Invest 2025: The top question that must be answered
PFE

Yahoo Finance

17 days ago

Inside Yahoo Finance Invest 2025: The top question that must be answered

Valuation worries, record-long government shutdown hang over markets: What to watch this week
PFE

Yahoo Finance

17 days ago

Valuation worries, record-long government shutdown hang over markets: What to watch this week

Jim Cramer Says Haleon’s “Stock’s Been Struggling”
PFE

Insider Monkey

17 days ago

Jim Cramer Says Haleon’s “Stock’s Been Struggling”

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
PFE

Associated Press Finance

18 days ago

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

2 No-Brainer Dividend Stocks to Buy With $100 in November
PFE

Motley Fool

18 days ago

2 No-Brainer Dividend Stocks to Buy With $100 in November

This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed.
PFE

The Wall Street Journal

18 days ago

This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed.

Share on Social Networks: